The triple-negative breast cancer cell line MDA-MB-468 exhibits genomic alterations including overexpression of EGFR, mutant p53, and PTEN proteins, and does not express functional retinoblastoma (Rb) protein [27]. This evidence concerns the gene TP53 and triple-negative breast carcinoma.